Drug General Information
Drug ID	D0GN5Z
Former ID	DNC011373
Drug Name	SULFURETIN
Drug Type	Small molecular drug
Indication	Discovery agent		Investigative	[531262]
Structure		Download 2D MOL 3D MOL
Formula	C15H10O5
Canonical SMILES	C1=CC(=C(C=C1C=C2C(=O)C3=C(O2)C=C(C=C3)O)O)O
InChI	1S/C15H10O5/c16-9-2-3-10-13(7-9)20-14(15(10)19)6-8-1-4-11(17)12(18)5-8/h1-7,16-18H/b14-6-
InChIKey	RGNXWPVNPFAADO-NSIKDUERSA-N
PubChem Compound ID	5281295
Target and Pathway
Target(s)	Induced myeloid leukemia cell differentiation protein Mcl-1	Target Info	Inhibitor	[531262]
KEGG Pathway	PI3K-Akt signaling pathway
	MicroRNAs in cancer
NetPath Pathway	TCR Signaling Pathway
PANTHER Pathway	Apoptosis signaling pathway
	CCKR signaling map ST
Pathway Interaction Database	E2F transcription factor network
	Direct p53 effectors
	IL6-mediated signaling events
	HIF-1-alpha transcription factor network
WikiPathways	Apoptosis
	miR-targeted genes in muscle cell - TarBase
	miR-targeted genes in lymphocytes - TarBase
	miR-targeted genes in leukocytes - TarBase
	Apoptosis Modulation and Signaling
References
Ref 531262	Bioorg Med Chem Lett. 2010 Dec 15;20(24):7331-6. Epub 2010 Oct 21.In silico identification and biochemical evaluation of novel inhibitors of NRH:quinone oxidoreductase 2 (NQO2).
Ref 531262	Bioorg Med Chem Lett. 2010 Dec 15;20(24):7331-6. Epub 2010 Oct 21.In silico identification and biochemical evaluation of novel inhibitors of NRH:quinone oxidoreductase 2 (NQO2).

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.